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Abstract

Introduction

Many studies indicate that up-regulated production
of 1,25(0H)rvitamin D3 (calcitriol) with increased intestinal absorption of calcium is the primary event causing idiopathic hypercalciuria. Thus, a low calcium diet
appears to be a straightforward strategy in calcium stone
formers withhypercalciuria (HCSF). However, the efficacy of such a regimen has never been established, and
lowering calcium intake from 1000 to 400 mg/day further enhances calcitriol production. On a diet chronically restricted in calcium, many stone formers increase
their intake of animal flesh protein. The latter is known
to increase renal mass, and calcitriol levels indeed are
positively correlated with renal mass in animals as well
as in HCSF. Thus, low calcium and high animal flesh
protein consumption are independent stimuli for further
up-regulation of calcitriol production. The rise in calcitriol suppresses parathyroid hormone synthesis
thereby diminishing renal tubular calcium reabsorption ,
and increasing urinary calcium losses. Since calcitriol
up-regulation also increases bone resorption, the combination of low calcium and high protein intake is particularly likely to induce negative calcium balance and thus
osteopenia. Finally, low calcium intake carries the risk
of insufficient intestinal binding of oxalate with subsequent increases in intestinal absorption and urinary
excretion of oxalate. Indeed, most recent studies suggest that high amounts of calcium, when ingested simultaneously with oxalate-containing meals, are able to
prevent hyperoxaluria during severe oral oxalate loading.

Already in 1939, Flocks [20] wrote that, "although
the high concentration of the calcium in the urine of
itself is not enough to bring about precipitation in the
kidney substance or in the urinary passageway," hypercalciuria might predispose people to form kidney stones.
More than half a century later, we still are quite uncertain about the pathophysiologic relevance of hypercalciuria in nephrolithiasis: in his latest review, Breslau [9]
only stated that "hypercalciuria could cause or contribute
to calcium stone formation . " The following discussion
is focused on the pathophysiology of hypercalciuria and
hyperoxaluria as well as on the question of whether
these abnormalities directly cause calcium oxalate stone
disease, or whether they are rather associated with other
underlying defects that induce stone formation .

Physico-Chemical Considerations
Particle formation within the urinary tract is ultimately driven by increased urinary supersaturation with
respect to stone forming salts on one hand and, probably
more important, by an abnormally increased tendency to
form large crystal aggregates in stone formers on the
other hand [29] . As elegantly pointed out by Robertson
et al. [49], the volume of calcium oxalate crystals precipitated from freshly voided urines of stone formers exponentially increases with rising concentrations of urinary oxalate, but is largely independent of urinary calcium.
This is due to the fact that calcium is always present in
urine in excess over oxalate so that, due to the formation
of soluble complexes, increases in ionized calcium are
almost entirely offset by proportional decreases in ionized oxalate [49]. On the other hand, rises in urinary
oxalate in the presence of constant calcium concentrations immediately are followed by increased precipitation
of calcium oxalate crystals [49].
Clinically, these findings are highly relevant in that
slight increases in urinary oxalate are much more important for calcium renal stone formation than respective
rises in urinary calcium [49]. Indeed, it has been known
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for many years that the severity of stone disease does
not correlate with daily urinary calcium excretion [19],
but strongly depends on oxalate excretion rates [47] .
Nevertheless, urinary calcium has attracted considerably
more interest by those involved in stone research than
urinary oxalate, probably for two very simple reasons:
an overwhelming 80 % of renal stones consist of calcium
salts, and until recently, measurements of calcium in
urine have been much easier to perform than measurements of oxalate [6] .

centrations of the main modulators of calcitriol, namely
blood ionized calcium, phosphate and parathyroid hormone (PTH) [reviewed in 28] . Alternatively, an increased number of calcitriol receptors might be present
[9]. Thus, a low-calcium diet appeared to be a straightforward strategy. However, no prospective trial has
ever established the efficacy of such a regimen with
respect to stone recurrence [39] .
The consequences of a low calcium diet have been
studied in healthy controls as well as in patients with IH:
in healthy subjects, dietary calcium deprivation induces
a significant rise in serum calcitriol levels within 48
hours [1]. In patients with 1H and nephrolithiasis, lowering calcium intake from 1000 mg/day to 400 mg/day
more pronouncedly enhances calcitriol production than
in normocalciuric stone formers, and serum calcitriol
levels are abnormally high in the majority of patients
with IR [10]. Thus, a low calcium diet appears to additionally amplify what has been recognized as the primary
defect in IH, i.e., abnormally up-regulated production of
calcitriol.
Since stone formers, when given the advice of a low
calcium diet, have to get their protein from other
sources than dairy products, they usually increase their
intake of animal flesh protein (meat, fish, poultry).
Indeed, overconsumption of animal flesh protein has
long been recognized as a major risk factor for IH [24,
46]. Chronic overconsumption of meat protein is also
known to increase glomerular filtration rate and renal
size, an effect which is usually more pronounced in animals than in humans [8, 37] . Nevertheless, striking
increases in renal size have been described in patients
receiving large amounts of amino acids during intravenous (i.v.) hyperalimentation [12]. Animal studies
have demonstrated that calcitriol production rates are
strongly and positively related to renal mass [51], i.e.,
larger kidneys produce more a-hydroxylase and thus
more calcitriol.
Accordingly, we recently demonstrated that male
calcium stone formers with IH had larger kidneys than
their normocalciuric counterparts, and that renal mass
directly correlated with urinary phosphate excretion rates
as a marker of daily protein consumption in the steady
state [33]. Furthermore, serum calcitriol levels were
positively correlated with renal mass, suggesting that
overconsumption of animal flesh protein, by means of an
increase in renal mass, may be yet another stimulus for
up-regulation of calcitriol production in 1H [33]. In
summary, the already increased calcitriol activity in
many calcium stone formers with IH may additionally be
up-regulated by dietary calcium restriction and high intake of animal flesh protein, as depicted in Figure 1.
The observed rise in calcitriol activity, however, is
expected to down-regulatePI'H activity (Fig. 1): on one

Idiopathic Hypercalciuria
Idiopathic hypercalciuria (IH) is a syndrome characterized by normocalcemia, a low serum phosphorus level
and increased urinary calcium excretion [2] which cannot be explained by clearly established causes of hypercalciuria such as primary hyperparathyroidism, sarcoidosis, excessive vitamin D intake, hypercalciuria due to
hypercalcemia of malignancy or immobilization, medullary sponge kidneys or renal tubular acidosis [28]. Idiopathic hypercalciuria can be found in more than half of
all patients with calcium nephrolithiasis [15] and in
about 5-10% of normal people [38] .
Many studies have attempted to distinguish between
primary "absorptive" and primary "renal" types of IH
[reviewed in 28] . Already in 1968, Liberman et al. [41]
concluded "that the primary disturbance in idiopathic
hypercalciuria is neither intestinal hyperabsorption nor
urinary hyperexcretion of calcium, but both these ... ,
leading to a high calcium turnover, possibly due to some
as yet unknown hormonal imbalance." This perfectly
anticipated forthcoming studies on the pathophysiology
of IH. Indeed, a substantial body of evidence supports
the view that "absorptive" and "renal" hypercalciuria are
not distinct entities, but rather two extremes of a continuum behaviour [13, 14]. However, many studies [reviewed in 28] indicate that an increase in intestinal absorption of calcium is the primary event, either because
calcitriol production is up-regulated, or, in patients with
IH in whom serum calcitriol concentrations are not elevated, due to an increased sensitivity of the intestine and
the parathyroid glands to calcitriol.
Accelerated intestinal calcium transport and the
kidneys
Already in 1958, Henneman et al. [26] presented
evidence that increased intestinal absorption of calcium
was the backbone of IH. This was later confirmed by
others [5, 41, 62] and further supported by several
studies demonstrating, for reasons not yet fully elucidated, that patients with IH exhibit increased or highnormal serum levels of 1,25(OH)i-vitaminD3 (calcitriol)
which are clearly up-regulated in the face of the con548
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Figure 1. Three-fold stimulus for increased calcitriol activity in patients with idiopathic hypercalciuria on a low
calcium/high animal flesh protein diet (meat, fish, poultry) , inducing down-regulation of PTH synthesis. For details,
see text.

hand, increases in calcitriol decrease the transcription of
the PTH gene [54]; on the other hand, the calcitriol-mediated rise in intestinal calcium absorption induces steeper transient increases in blood ionized calcium after
meals and thereby produces, repeatedly, another stimulus for down-regulating PTH secretion in HCSF [34].
Indeed, in comparison with their normocalciuric counterparts, hypercalciuric calcium renal stone formers studied
on their individual homeostasis (free-choice diet) exhibit
an imbalance between calcitriol and PTH activities with
relative hypoparathyroidism [31, 34] . The latter induces a decrease in renal tubular reabsorption of calcium
and thereby contributes to increased excretion of a given
daily load of calcium.

Moreover, the combination of a low calcium, high
animal flesh protein diet appears particularly likely to
induce a negative calcium balance and a loss of bone
mineral, at least when applied for several days or weeks
[reviewed in 24) . In calcium renal stone formers, an increased sensitivity to the hypercalciuric action of dietary
protein has been described [61], and balance studies indicate that, at any given level of net intestinal absorption
of calcium, negative calcium balance is clearly more frequent in stone patients with IH than in normal people
[3]. Therefore, it is not surprising that several studies
have demonstrated decreased bone mineral density in
calcium stone formers with 1H [4, 7, 21, 31, 43, 44).
Whereas studies in the United States usually were performed in patients adhering to a low calcium diet, at
least two European studies clearly indicate that bone
mineral density is lower in stone formers who have been
adhering to a low calcium diet for several years than in
those who have not been compliant with such a regimen
[21, 31).

Accelerated calcium transport: bone
Besides its effects at intestinal and renal levels, upregulation in .:alcitriol synthesis also affects calcium
transport in bone, i.e., bone resorption is increased in
patients with 1H [41). When healthy volunteers, on a
low calcium diet (4 mM/day), were given calcitriol, urinary calcium excretion by far exceeded intestinal calcium absorption and thus produced negative calcium balance; this was not the case when calcitriol was administered to the same subjects consuming 22 mM calcium
per day [42). Therefore, the combination of calcitriol
excess and low calcium intake produces two essential
features of IH, i.e., absorptive hypercalciuria and bone
mineral loss [13, 38).

Low calcium diet: conclusions
Altogether, available data clearly indicate that a low
calcium diet as a treatment for idiopathic calcium
nephrolithiasis should be abandoned, because it may induce negative calcium balance. Since many patients appear very reluctant to change their long-standing dietary
habits, they should carefully be advised on a diet moderately restricted in animal flesh protein and sodium which
549
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In stone formers on a low calcium diet, secondary
increases in urinary oxalate have been observed by several authors [reviewed in 58] . Thus, secondary hyperoxaluria most likely accounts for high stone recurrence
rates in patients on a low calcium diet [39] . In addition,
stone formers with calcitriol-mediated hyperabsorption
of calcium may even become hyperoxaluric while calcium intake is normal: since less calcium is left behind
more distally in the gut, more oxalate is freely available
for absorption. Indeed, Giannini et al. [22] found a positive correlation between urinary oxalate excretion rates
and serum calcitriol levels. Finally, patients with intestinal malabsorption due to inflammatory bowel disease
with or without bowel resection or after jejunoileal bypass surgery also may exhibit secondary hyperoxaluria
even when intake of calcium is normal [reviewed in 58].
This emphasizes the importance of sufficient unbound
calcium present in the intestinal lumeu relative to the
amount of oxalate provided with a specific diet.

contains 800 mg (20 mmol) calcium from dairy products
per day, provided that oxalate intake is not exceedingly
high (see following paragraphs). Compliance with this
regimen should be assessed by repeatedly measuring urinary excretion rates of calcium as well as of urea and
sodium. Together with simultaneous calculations of calcium intake from diet questionnaires, these data can help
to get an idea of the patients' calcium balance.
Hyperoxaluria
Increased intestinal oxalate absorption and low
calcium diet
There is yet another reason why a low calcium diet
may be contra-indicated in stone formers with IH. Recently, Curhan et al. [16] published a large prospective
trial indicating that de novo stone formation occurs at
increasing rates with decreasing daily calcium conswnption. Although not proven by this study, the lack
of sufficient oxalate binding by the reduced amount of
calcium available in the intestinal lumen must have increased oxalate absorption and thus urinary oxalate excretion [55, 58]. Indeed, a recent study of our own
group [35] demonstrated that 6 healthy subjects ingesting
2220 mg oxalate/day (about 20-times the amount usually
ingested) only became hyperoxaluric (695 ± 135 mmol/
day) when the diet contained 1200 mg of calcium per
day , but not when calcium content of the otherwise unchanged diet was increased to 3840 mg/day (279 ± 48
mmol/day, p = 0.028). On the latter diet, urinary calcium excretion rate amounted to 7.96 ± 0.93 mmol/day,
compared to 3.36 ± 0.54 mmol/day on the diet containing 1200 mg of calcium per day (p = 0.028). However, urinary calcium oxalate supersaturation, calculated
by using the index proposed by Tiselius [59], even tended to be lower on the calcium-rich diet (0.27 ± 0.08)
than on a normal calcium intake (0.44 ± 0. 10, not
significant).
In a recent study, Lemann et al. [40] found that
body size is the more important determinant of urinary
oxalate excretion than calcium intake among healthy
adults, possibly because endogenous oxalate synthesis
changes with lean body mass. However, while we studied subjects whose intakes of animal flesh protein and
calcium, both known to affect urinary oxalate excretion
[46, 55, 58] , were strictly controlled, Lemann et al. [40]
studied subjects on free-choice diet in whom intakes of
protein and calcium, assessed by a semiquantitative
questionnaire, widely varied between 27 and 207 g/day
and 6.2 and 65.6 mmol/day, respectively. In these
healthy volunteers, increasing calcium intake only appeared to affect urinary oxalate excretion up to the range
of 15-20 mmol/day, presumably by limiting intestinal
absorption of dietary oxalate [40].

Increased endogenous production of oxalate
Normally, only 10-15% of urinary oxalate is derived from the diet, the remainder coming from endogenous production [55, 58] . On one hand, ascorbic acid
is metabolized to oxalate; recent studies, however, suggest that up to 4 g of ascorbic acid may be daily ingested without significantly increasing urinary oxalate [reviewed in 58]. On the other hand, positive correlations
between oxalate and urinary markers of protein intake
have been observed by others [58] as well as by ourselves (unpublished). The same correlations have been
found for glycolate, a metabolic precursor of oxalate.
Robertson [46] has emphasized that overconsumption of
animal flesh protein, as often the case in patients adhering to a low calcium diet (see previous paragraphs),
increases the metabolic production of oxalate from precursors such as hydroxyproline and tryptophan. Under
these circumstances, mild hyperoxaluria, arbitrarily defined as a urinary oxalate excretion rate below 1.0
mmol/day [58] , may ensue. The term "mild metabolic
hyperoxaluria" originally has been used to describe a
subset of recurrent calcium oxalate stone formers with
mildly elevated urinary oxalate and glycolate excretions
in whom pyridoxine therapy sometimes caused a complete remission [23]. It remains to be seen whether or
not "mild metabolic hyperoxaluria" represents an incomplete form of primary hyperoxaluria [58].
In some patients, endogenous oxalate overproduction
may persist although there is no evidence for animal
protein overconsumption, due to a lack of pyridoxine or
an impairment of conversion of pyridoxine to pyridoxal5' -phosphate [17]. As a result, glyoxylate, the immediate precursor of oxalate, is not sufficiently converted to
glycine, whereby more glycolate and oxalate are being
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Table 1. Causes of hyperoxaluria. Bold letters: most frequently encountered causes.

Mild metabolic hyperoxaluria

Non-metabolic (enteric) hyperoxaluria
U0x x V

>

UGlyc

X

U0x x V

V

<

UGlyc x V

• low calcium diet / calcium binders

• animal protein overconsumption

• intestinal malabsorption

• pyridoxine deficiency / I conversion
pyridoxine - pyridoxal-5'-phosphate.

• excessive intake of oxalate-rich foods
U 0 x: urinary oxalate;

UGlyc: urinary glycolate;

V: urine volume/ day

Stone disease
"Bad" dietary habits

Figure 2. The "powder keg and tinderbox theory,• explaining the "idiopathic" formation of calcium oxalate renal
stones [adapted from ref. 36]. For details, see text.

formed [45) . Only for such specific cases, but certainly
not for the general calcium oxalate stone former with
mild hyperoxaluria, a therapeutic trial of pyridoxine
supplements appears to be warranted [58).

sumption of meat protein is associated with increased
risk of stone formation [46) . However, such "bad eating
habits," despite that they induce hypercalciuria and hyperoxaluria as well as hyperuricosuria and hypocitraturia
[36), do not automatically lead to calcium renal stone
formation, and many non-stone formers are very likely
to have them as well [36). As summarized in Figure 2,
it is only the combination of a powder keg, i.e., underlying (inherited or acquired) abnormalities, and a tinderbox, i.e., "bad eating habits," that finally leads to
an explosion, i.e., renal stone formation [36) .
One of the underlying abnormalities which appears
to be of utmost relevance for stone formation has been
described in severely recurrent calcium renal stone formers by Robertson et al. [48): under identical conditions
of oral oxalate loading, urines of patients with accelerated calcium nephrolithiasis contained larger crystals

Summary

Our first diagnostic approach to patients with calcium nephrolithiasis and mild hyperoxaluria (usually <
1000 µmol/day) always consists of establishing the metabolic or non-metabolic origin of hyperoxaluria. As outlined in Table 1, this is based on measurements of urinary glycolate.
Idiopathic Calcium Nephrolithiasis:
Only due to "Bad Eating Habits"?

Epidemiologically, there is no doubt that high con551
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than urines of healthy controls, and often these crystals
were fused into very large polycrystalline aggregates.
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of calcium oxalate crystallization [reviewed in 27].
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calcium oxalate crystal aggregation [32). As soon as the
effect of free calcium ions on THP molecules is antagonized by chelate formation with citrate, stone former
THPs again inhibit calcium oxalate crystal aggregation
[32].
These findings confirm that functional properties of
macromolecules in urine may be strongly affected by
free calcium ions [9] and thus by the presence of hypercalciuria. They also emphasize the importance of sufficient urinary citrate concentrations for the activity of
some macromolecular inhibitors [60] and thereby once
again confirm that hypocitraturia is an important risk
factor for calcium nephrolithiasis. Regarding recurrent
renal stone formation, one has to conclude that it is only
by the interplay of "bad eating habits" (tinderbox) and
additional underlying abnormalities (powder keg) that
people become highly active renal stone formers .
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Discussion with Reviewers
G.C. Curhan: The title of the paper is "Low calcium
diet in hypercalciuric calcium nephrolithiasis." Over
50 % of patients who form calcium stones are not hypercalciuric. Are your recommendations on calcium and
animal protein intake applicable to patients with calcium
nephrolithiasis but who are not hypercalciuric?
Authors: Yes, they are. Reducing protein intake to 0. 81.0 g/kg of body weight and consuming 800 mg of
calcium from dairy products are not specific measures
for patients with calcium nephrolithiasis, but rather part
of a well-equilibrated "common sense-diet." In addition,
our own experience (unpublished data) requires that high
fluid intake is even more emphasized in normocalciuric
calcium stone formers, since they usually have lower
urine volumes than hypercalciurics.
G.C. Curhan: As the urinary calcium concentration always exceeds that of oxalate, is there any maximum
amount of calcium that can be ingested without increasing the risk of crystal formation?
Author: As demonstrated by the studies of Robertson
et al., the volume of crystals precipitated from urines
[49] as well as the severity of stone disease [47] do not
depend on urinary calcium, but strongly increase with
increasing urinary oxalate concentrations. Therefore,
one might argue that very high urinary calcium concentrations would be tolerated without any further consequences for stone formation. On the other hand, increasing urinary calcium concentrations might change
the functional properties of macromolecular inhibitors
and turn them into crystallization promoters, as demonstrated for Tamm-Horsfall glycoprotein [32]. The
amount of calcium that can be consumed without any
risk for stone formation also depends on the amounts of
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oxalate or phosphate which are simultaneously ingested
and will co-precipitate with calcium in the intestinal
lumen. In our preliminary study [35], where 2220 mg
of oxalate were ingested per day, calcium intake was as
high as 3840 mg/day; this was tolerated without any
problem, and urinary calcium oxalate supersaturation
even tended to fall in comparison with the day where the
same subjects consumed 2220 mg of oxalate together
with 1200 mg of calcium.

hypercalciuria?
Author: Previous studies by Broadus et al. [11] as well
as by ourselves [31] demonstrated a significant negative
correlation between fasting urinary calcium excretion
and cyclic AMP or intact PTH, respectively, indicating
that PTH suppression indeed could be causative with respect to IH. Considering a patient consuming constant
amounts of protein, salt and calcium, one certainly
would predict that any suppression of PTH secretion
would lead to hypercalciuria, followed by a fall in blood
ionized calcium with a subsequent increase in PTH secretion, whereby hypercalciuria would be transient.
However, we often see stone patients in whom hypercalciuria persists, even if their calcium intake is very low,
and many of them exhibit overconsumption of animal
flesh protein and/or salt. The relatively low-normal
levels of intact PTH that we find in these patients on low
calcium/high protein diet can be explained by their inappropriately high calcitriol levels [31, 33]. This appears to indicate that low calcium intake, especially
when combined with high protein consumption, inappropriately stimulates calcitriol production more than it increases PTH secretion in patients with IH, leading to the
observed mutual imbalance of the 2 hormones [34] .

G.C. Corban: Calcium supplements, typically in the
form of calcium carbonate, are used by many individuals
for prevention of osteoporosis. Can calcium supplements replace dairy or other dietary sources of calcium?
Author: According to Sheikh et al. [52], intestinal calcium absorption from calcium salts (carbonate, acetate,
lactate, gluconate and citrate) and from whole milk is
similar. When comparing the availability of calcium for
absorption from dairy foods (whole milk, skim milk and
Cheddar cheese), non-dairy foods (collards, oatmeal)
and calcium salts (calcium gluconate and calcium carbonate), Spencer and Norris [55] did not find any difference between the 7 sources of calcium. Therefore, calcium supplements certainly may (and often have to) replace dietary sources of calcium.

R.A.L. Sutton: In view of the adaptation to low calcium intakes, would monitoring of the urinary calcium
really be of value in checking the patients compliance
with an adequate calcium intake?
Author: In order to get information on the patient's
intakes of protein, salt and calcium, we measure urinary
excretion rates of urea, salt and calcium. By considering these measurements together with the patient's diet
history, we certainly can get some (semi-quantitative)
idea of the patient's compliance with our dietary advice
and approximately of his calcium balance. For instance,
we recently saw a 24-year old man, body weight (BW)
84 kg, with recurrent calcium stone disease whose daily
protein consumption, based on urinary urea excretion,
amounted to 138 g or 1.64 g/kg BW. He denied consuming any dairy products; thus, his daily calcium intake at the time of investigation did not exceed 400 mg.
If we assume that calcitriol production must have been
stimulated by the very low calcium intake and that net
intestinal absorption of calcium could have been as high
as 50 %, the patient might have absorbed 200 mg of the
ingested calcium. However, urinary calcium excretion
rate was 377 mg/day, thus, the patient was hypercalciuric. At least at the time of investigation, he must have
been in negative calcium balance.

R.A.L. Sutton: Not all studies report elevated calcitriol
levels in idiopathic hypercalciuria. What does the author
consider to be the relative importance of increased calcitriol production versus hypersensitivity to calcitriol in
the production of idiopathic hypercalciuria?
Author: So far, direct evidence for calcitriol hypersensitivity has only been provided in rats with absorptive
hypercalciuria whose calvariae were hypersensitive to
calcitriol-induced bone resorption in vitro [56]. In
humans, hypersensitivity to calcitriol remains rather speculative, whereas elevated calcitriol levels in patients
with IH have repeatedly been found [reviewed in 28].
When studying subjects on a very low calcium diet, Coe
et al. [14] found normal calcitriol levels; however, they
were inappropriately elevated with respect to the relatively low PTH levels. Very similar findings were obtained in hypercalciuric calcium stone formers on freechoice diet [31], indicating that calcitriol and PTH are
in mutual imbalance in patients with 1H [34] . In
humans, it is still hypothetical that this might indicate
hypersensitivity to calcitriol [9].
R.A.L. Sutton: Would not PTH suppression lead to
transient hypercalciuria, followed by a return to the
base-line urinary calcium level accompanied by a lower
serum ultra-filtrable calcium, i.e., to increased fractional
rather than absolute urinary calcium excretion? In other
words, is PTH suppression causative with respect to

G.A. Rose: In any discussion of the treatment of renal
stones, there should be a reference to the value of high
water intake. Why has this been omitted?
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Author: To discuss the value of high water intake is
beyond the scope of a pathophysiology-oriented review
of idiopathic hypercalciuria. Nevertheless, high water
intake is undoubtedly one of the most important issues
in the treatment of renal stones. This appears to be
particularly true with respect to the role of THP in renal
stone formation. Several studies [25, 30, 32, 51] have
indicated that THP molecules progressively lose their
inhibitory activity towards calcium oxalate crystallization
processes with increasing ionic strength/osmolality of the
solution or with rising concentrations of THP itself.
This provides an additional basis for high fluid intake as
treatment of idiopathic calcium nephrolithiasis.
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